Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery

Conclusions: This study demonstrated that the intraoperative use of dexmedetomidine to NSCLC patients was not associated with a significant impact on RFS and but worsening OS. A randomized controlled study should be conducted to confirm the results of this study.

Source: Journal of Anaesthesiology Clinical Pharmacology - September 11, 2017 Category: Anesthesiology Authors: Juan P Cata Vinny Singh Brenda M Lee John Villarreal John R Mehran J Yu Vijaya Gottumukkala Hagar Lavon Shamgar Ben-Eliyahu Source Type: research